HR Execs on the Move

Immunovant

www.immunovant.com

 
Immunovant is a biopharmaceutical company committed to developing innovative therapies that not only treat the symptoms, but modify the course of autoimmune diseases. Our primary investigational product candidate is RVT-1401, a human recombinant anti-FcRn monoclonal antibody that is being developed with a focus on patient need, and may be applicable to a wide array of autoimmune diseases. We are currently assessing RVT-1401 in a single and multiple ascending dose Phase 1 clinical trial. We plan on initiating a number of patient-based studies in early 2019, focusing on Myasthenia gravis (MG) and other IgG-mediated diseases. We also seek to continue expanding ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.immunovant.com
  • 320 West 37th Street 5th Floor
    New York, NY USA 10018
  • Phone: 212.847.6204

Executives

Name Title Contact Details
Kathryn Bednarz
 Director, Clinical Laboratories Profile
Shari Duralek
 Director Global Clincial Supply Chain Profile
Steven Hagler
 Director, Technical Accounting and SEC Reporting Profile
Elise McCarthy
 Associate Director, Vendor Quality Assurance Profile
Daniel Isaacman
 Vice President Clinical Research Profile

Similar Companies

IGM Biosciences

IGM Biosciences, Inc. is a privately held biotechnology company that has been focused on creating and developing novel IgM and IgA antibodies that improve the treatment of cancer and other diseases since 2010.

Myrexis

Myrexis, Inc. is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Nocion Therapeutics

NOCION is a biopharmaceutical company that is addressing vexing medical problems head on. We are developing `nocions`—a new kind of therapy that selectively affects actively firing nocioceptors—to provide targeted, robust and sustained relief for the treatment of serious conditions including cough, itch, pain and inflammation.

Presbia

Presbia is a medical device company focused on the development of the presbyopia-correcting Presbia Flexivue Microlens™ – an innovative solution for the common age-related loss of the ability to read or focus on near objects. The 3mm diameter lens is implanted in a corneal pocket created by a femtosecond laser.

Amisure International

Amisure International is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.